BMP2 and infection: genetically modified iPSC‐MSCs for BMP2 delivery by green fluorescent protein GFP‐iPSC‐MSCs or BMP2‐iPSC‐MSCs infection and inoculated BMP2 gene‐modified iPSC‐MSCs bone tissue engineering on CPC fixed with RGD RT‐PCR, and ELISA results showed that BMP2‐iPSC‐MSCs showed higher levels of BMP2 than iPSC‐MSCs (p < 0.05) and did not impair cell growth compared to iPSC‐MSC (Figure 10B).